How big is the Large Molecules Drug Substance CDMO Market?

The Large Molecules Drug Substance CDMO Market size is expected to reach USD 11.14 million in 2024 and grow at a CAGR of 8.60% to reach USD 18.76 million by 2029. Read More

What is the current Large Molecules Drug Substance CDMO Market size?

In 2024, the Large Molecules Drug Substance CDMO Market size is expected to reach USD 11.14 million. Read More

Who are the key players in Large Molecules Drug Substance CDMO Market?

Thermo Fisher Scientific Inc., Eurofins Scientific, Wuxi Biologics, Samsung Biologics and Catalent, Inc. are the major companies operating in the Large Molecules Drug Substance CDMO Market. Read More

Which is the fastest growing region in Large Molecules Drug Substance CDMO Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Large Molecules Drug Substance CDMO Market?

In 2024, the North America accounts for the largest market share in Large Molecules Drug Substance CDMO Market. Read More

What years does this Large Molecules Drug Substance CDMO Market cover, and what was the market size in 2023?

In 2023, the Large Molecules Drug Substance CDMO Market size was estimated at USD 10.18 million. The report covers the Large Molecules Drug Substance CDMO Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Large Molecules Drug Substance CDMO Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Large Molecules Drug Substance CDMO Companies

This report lists the top Large Molecules Drug Substance CDMO companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Large Molecules Drug Substance CDMO industry.